{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T21:34:41Z","timestamp":1768080881270,"version":"3.49.0"},"reference-count":18,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","amjmedsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of the Medical Sciences"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.amjms.2018.08.013","type":"journal-article","created":{"date-parts":[[2018,8,29]],"date-time":"2018-08-29T17:12:51Z","timestamp":1535562771000},"page":"537-543","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Galectin-3: A Novel Biomarker Predicts Sudden Cardiac Death in Hypertrophic Cardiomyopathy"],"prefix":"10.1016","volume":"356","author":[{"given":"Samim","family":"Emet","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mubariz","family":"Dadashov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehmet Rasih","family":"Sonsoz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mustafa Ozan","family":"Cakir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mustafa","family":"Yilmaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Elitok","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmet Kaya","family":"Bilge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fehmi","family":"Mercanoglu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aytac","family":"Oncul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kamil","family":"Adalet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Imran","family":"Onur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjms.2018.08.013_bib0001","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1053\/euhj.1997.0735","article-title":"Familial hypertrophic cardiomyopathy. Cardiac ultrasonic abnormalities in genetically affected subjects without echocardiographic evidence of left ventricular hypertrophy","volume":"19","author":"Hagege","year":"1998","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjms.2018.08.013_bib0002","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1161\/01.CIR.104.2.128","article-title":"Tissue Doppler imaging consistently detects myocardial abnormalities in patients with hypertrophic cardiomyopathy and provides a novel means for an early diagnosis before and independently of hypertrophy","volume":"104","author":"Nagueh","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.amjms.2018.08.013_bib0003","series-title":"Heart Disease A Textbook of Cardiovascular Medicine","first-page":"1760","article-title":"Hypertrophic cardiomyopathy","author":"Wynne","year":"2012"},{"key":"10.1016\/j.amjms.2018.08.013_bib0004","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1016\/S0735-1097(03)00941-0","article-title":"ACC\/ESC clinical expert consensus document on hypertrophic cardiomyopathy","volume":"42","author":"Maron","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjms.2018.08.013_bib0005","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s00392-012-0500-y","article-title":"Galectin-3 is an independent marker for ventricular remodeling and mortality in patients with chronic heart failure","volume":"102","author":"Lok","year":"2013","journal-title":"Clin Res Cardiol"},{"issue":"6","key":"10.1016\/j.amjms.2018.08.013_bib0006","first-page":"595","article-title":"Galectin-3 in patients with chronic heart failure: association with oxidative stress, inflammation, renal dysfunction and prognosis","volume":"64","author":"Medvedeva","year":"2016","journal-title":"Minerva Cardioangiol"},{"key":"10.1016\/j.amjms.2018.08.013_bib0007","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.cca.2017.12.041","article-title":"Galectin-3 in patients with coronary heart disease and atrial fibrillation","volume":"478","author":"Kang","year":"2018","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.amjms.2018.08.013_bib0008","doi-asserted-by":"crossref","unstructured":"Francia P, Adduci C, Semprini L, et al. Osteopontin and galectin-3 predict the risk of ventricular tachycardia and fibrillation in heart failure patients with implantable defibrillators. J Cardiovasc Electrophysiol, 25(6), 609\u2013616.","DOI":"10.1111\/jce.12364"},{"key":"10.1016\/j.amjms.2018.08.013_bib0009","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1093\/eurheartj\/eht439","article-title":"A novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM Risk- SCD)","volume":"35","author":"O'Mahony","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjms.2018.08.013_bib0010","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1056\/NEJMoa1002659","article-title":"Myocardial fibrosis as an early manifestation of hypertrophic cardiomyopathy","volume":"363","author":"Ho","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjms.2018.08.013_bib0011","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1136\/hrt.2010.217182","article-title":"The long-term survival and the risks and benefits of implantable cardioverter defibrillators in patients with hypertrophic cardiomyopathy","volume":"98","author":"O'Mahony","year":"2012","journal-title":"Heart"},{"key":"10.1016\/j.amjms.2018.08.013_bib0012","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1093\/eurheartj\/ehu284","article-title":"2014 ESC guidelines on diagnosis and management of hypertrophic cardiomyopathy: the task force for the diagnosis and management of hypertrophic cardiomyopathy of the European Society of Cardiology (ESC)","volume":"35","author":"Elliott","year":"2014","journal-title":"Eur Heart J"},{"issue":"5","key":"10.1016\/j.amjms.2018.08.013_bib0013","first-page":"344","article-title":"Galectin-3 levels in patients with hypertrophic cardiomyopathy and its relationship with left ventricular mass index and function","volume":"15","author":"Yakar T\u00fcl\u00fcce","year":"2015","journal-title":"Anatol J Cardiol"},{"key":"10.1016\/j.amjms.2018.08.013_bib0014","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/S0735-1097(03)00827-1","article-title":"Non-sustained ventricular tachycardia in hypertrophic cardiomyopathy: an independent marker of sudden death risk in young patients","volume":"42","author":"Monserrat","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjms.2018.08.013_bib0015","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.jacc.2004.11.043","article-title":"Spectrum and prognostic significance of arrhythmias on ambulatory Holter electrocardiogram in hypertrophic cardiomyopathy","volume":"45","author":"Adabag","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjms.2018.08.013_bib0016","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1161\/01.CIR.59.5.866","article-title":"Prevalence of arrhythmias during 24-hour electrocardiographic monitoring and exercise testing in patients with obstructive and nonobstructive hypertrophic cardiomyopathy","volume":"59","author":"Savage","year":"1979","journal-title":"Circulation"},{"key":"10.1016\/j.amjms.2018.08.013_bib0017","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1093\/europace\/eut411","article-title":"Comparison of the patient activated event recording system vs. traditional 24h Holter electrocardiography in individuals with paroxysmal palpitations or dizziness","volume":"16","author":"De Asmundis","year":"2014","journal-title":"Europace"},{"key":"10.1016\/j.amjms.2018.08.013_bib0018","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.amjcard.2009.04.039","article-title":"Left ventricular outflow tract obstruction as a risk factor for sudden cardiac death in hypertrophic cardiomyopathy","volume":"104","author":"Efthimiadis","year":"2009","journal-title":"Am J Cardiol"}],"container-title":["The American Journal of the Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962918303410?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962918303410?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,10,23]],"date-time":"2019-10-23T04:49:53Z","timestamp":1571806193000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002962918303410"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":18,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["S0002962918303410"],"URL":"https:\/\/doi.org\/10.1016\/j.amjms.2018.08.013","relation":{},"ISSN":["0002-9629"],"issn-type":[{"value":"0002-9629","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Galectin-3: A Novel Biomarker Predicts Sudden Cardiac Death in Hypertrophic Cardiomyopathy","name":"articletitle","label":"Article Title"},{"value":"The American Journal of the Medical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjms.2018.08.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Southern Society for Clinical Investigation. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}